Snowden Capital Advisors’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
Snowden Capital Advisors's LMAT Position: Q1 2026 in Review
Snowden Capital Advisors reduced its LeMaitre Vascular (LMAT) stake by 21% in Q1 2026, selling an estimated $135K and leaving 5,195 shares worth $567K. The position accounts for 0.02% of the portfolio, ranked #742.
Snowden Capital Advisors first reported a position in LMAT in Q2 2022 and has held it in 16 quarters since. The position peaked at $713K in Q4 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- Snowden Capital Advisors held 5,195 shares of LeMaitre Vascular worth $567K as of Q1 2026.
- Snowden Capital Advisors sold 1,418 LeMaitre Vascular shares in Q1 2026, an estimated $135K.
- LeMaitre Vascular made up 0.02% of Snowden Capital Advisors's portfolio in Q1 2026, its #742 holding.
- Snowden Capital Advisors first reported a position in LeMaitre Vascular in Q2 2022 and has held it in 16 quarters since.
- Snowden Capital Advisors's LeMaitre Vascular position peaked at $713K in Q4 2024.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.